Home > Financial Ratios > CIPLA

CIPLA
Working Capital/Sales

    Back to All Ratios
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

CIPLA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 2.082.502.633.033.29

What is the latest Working Capital/Sales ratio of CIPLA ?

The latest Working Capital/Sales ratio of CIPLA is 2.08 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20252.08
Mar20242.50
Mar20232.63
Mar20223.03
Mar20213.29

How is Working Capital/Sales of CIPLA Trending?

Years Working Capital/Sales % Change
Mar2025 2.08
-16.80
Mar2024 2.5
-4.94
Mar2023 2.63
-13.20
Mar2022 3.03
-7.90
Mar2021 3.29 -

Other Financial Ratios of CIPLA


Compare Working Capital/Sales ratio of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹107,502.0 Cr 1.5% -9.3% -7.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics
MANKIND PHARMA ₹85,019.3 Cr -0.4% -10.9% -16.1% Stock Analytics


CIPLA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

1.5%

-9.3%

-7.3%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses